Prevention of Chronic Lung Disease (CLD) in premature infants with RDS

研究成果: 雜誌貢獻文章同行評審

摘要

Exogenous surfactant therapies significantly reduce mortality of the infants. However, the incidence of CLD is not clearly decreased by exogenous surfactant therapies, particulary in very low birth weight infants. The judicious use of diuretics and bronchodilators and the proper use of mechanical ventilation appeared to be beneficial in improving lung function and in decreasing oxygen requirement and barotrauma. However, these effects are often transient and appear to have no long term effect on CLD morbidity. Superoxide Dismutase and vitamin A may reduce CLD, but more studies are needed to confirm this conclusion. Dexamethasone given at two weeks or older does not affect CLD morbidity. The early use of Dexamethasone may decrease lung injuries and improve CLD morbidity. However, in order to avoid immediate side effects and possible long term adverse effect, a modified therapeutic regimen is needed.

原文英語
期刊Journal of the Singapore Paediatric Society
36
發行號SUPPL. 1
出版狀態已發佈 - 一月 1 1994
對外發佈Yes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

指紋 深入研究「Prevention of Chronic Lung Disease (CLD) in premature infants with RDS」主題。共同形成了獨特的指紋。

引用此